Mohamad Mohty,Junia V Melo
Mohamad Mohty
Yongxian Hu,Linqin Wang,Qu Cui et al.
Yongxian Hu et al.
The Incidence and Timing of Blood Cultures in Multiple Myeloma - Results from a Retrospective, Single Center, Real-World Study [0.03%]
多发性骨髓瘤中血液培养的发生率和时机-一项单中心回顾性的现实世界研究的结果
Agoston Gyula Szabo,Katrine Fladeland Iversen,Flemming Schønning Rosenvinge et al.
Agoston Gyula Szabo et al.
Joseph A Wilson,Stephanie Hayden,Alexander Asamoah et al.
Joseph A Wilson et al.
Emicizumab is increasingly the front-line treatment for patients with Hemophilia A with or without inhibitors. Rhabdomyolysis is a syndrome of muscle necrosis and release of intracellular muscle constituents into the circulation. Creatine k...
Monocyte Reconstitution and Gut Microbiota Composition after Hematopoietic Stem Cell Transplantation [0.03%]
血液干细胞移植后的单核细胞重建及肠道微生物群组成
Sejal Morjaria,Allen W Zhang,Sohn Kim et al.
Sejal Morjaria et al.
Background: Monocytes are an essential cellular component of the innate immune system that support the host's effectiveness to combat a range of infectious pathogens. Hemopoietic cell transplantation (HCT) results in tran...
Pierre Brissot,Eolia Brissot
Pierre Brissot
Major advances in the understanding of genetic iron overload have led to a clarification of the nosology and terminology of the related diseases. The term hemochromatosis should be reserved to the entities where iron overload is related to ...
Plasma Cell Leukemia - Facts and Controversies: More Questions than Answers? [0.03%]
浆细胞白血病的事实和争议：更多的问题还是答案？
Anna Suska,David H Vesole,Jorge J Castillo et al.
Anna Suska et al.
Plasma cell leukemia (PCL) is an aggressive hematological malignancy characterized by an uncontrolled clonal proliferation of plasma cells (PCs) in the bone marrow and peripheral blood. PCL has been defined by an absolute number of circulat...
Sorafenib Induced Complete Cytogenetic and Molecular Response in a Chronic Eosinophilic Leukemia Case with t(12;13) Translocation [0.03%]
索拉非尼对具有t（12;13）易位的慢性嗜酸性白血病诱导完全细胞遗传学和分子反应
Federica Ricci,Serena Balducci,Francesca Guerrini et al.
Federica Ricci et al.
Cost Analysis of R-CHOP Versus Dose-Adjusted R-EPOCH in Treatment of Diffuse Large B-Cell Lymphoma with High-Risk Features [0.03%]
高危特征的弥漫性大B细胞淋巴瘤中R-CHOP与剂量调整R-EPOCH治疗方案的成本分析
Bhagirathbhai Dholaria,Yenny Alejandra Moreno Vanegas,Nancy Diehl et al.
Bhagirathbhai Dholaria et al.
Dose-adjusted rituximab, etoposide, prednisone, vincristine, cyclophosphamide and doxorubicin (DA.R-EPOCH) is used for upfront treatment of high-risk diffuse large B cell lymphoma (DLBCL). In this study, we compared the outcomes in patients...
Framingham Risk Score Is an Ineffective Screening Strategy for Coronary Heart Disease in Long-Term Allogeneic Hematopoietic Cell Transplant Survivors [0.03%]
弗雷明汉风险评分是长期同种异体造血细胞移植幸存者冠心病无效的筛查策略
Natasha A Jain,Marcus Y Chen,Sujata Shanbhag et al.
Natasha A Jain et al.
Long-term allogeneic hematopoietic cell transplant (allo-HCT) survivors suffer an elevated risk of coronary heart disease (CHD). We conducted a prospective, nonrandomized, cross-sectional study to screen asymptomatic survivors at a single a...